Research Topics
| Richard HurtSummaryAffiliation: Mayo Clinic Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Open doorway to truth: legacy of the Minnesota tobacco trialRichard D Hurt
Division of Primary Care Internal Medicine, Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 84:446-56. 2009....
Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace lawsRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, Rochester, Minnesota 55905, USA
Arch Intern Med 172:1635-41. 2012..In 2002, a smoke-free restaurant ordinance was implemented in Olmsted County, Minnesota, and in 2007, all workplaces, including bars, became smoke free...
Preventing lung cancer by treating tobacco dependenceRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
Clin Chest Med 32:645-57. 2011..Treating tobacco dependence is one of the most cost-effective therapies in medicine and it deserves adequate reimbursement for it to be more widely available...
Roadmap to a tobacco epidemic: transnational tobacco companies invade IndonesiaRichard D Hurt
Mayo Clinic Nicotine Dependence Research Program, 200 First Street SW, Rochester, MN 55905, USA
Tob Control 21:306-12. 2012..Kreteks are clove/tobacco cigarettes that most Indonesians smoke...
Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional surveyJon O Ebbert
Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Environ Health 6:28. 2007..We undertook this study to evaluate the association between accumulated flight time in smoky airplane cabins and respiratory tract diseases in a cohort of never smoking flight attendants...
Treating tobacco dependence in a medical settingRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
CA Cancer J Clin 59:314-26. 2009..The effective treatment of tobacco dependence frequently requires tailoring, and often intensifying, interventions (both counseling and pharmacotherapy) to meet the needs of the individual patient...
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trialRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA
J Negat Results Biomed 10:1. 2011....
Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smokingRichard D Hurt
Mayo Clinic and Mayo Foundation, Rochester, MN, USA
J Clin Oncol 21:914-20. 2003..Participants and..
Pharmacotherapy for alcoholic smokersRichard D Hurt
Mayo Clinic, Nicotine Research Program, Rochester, Minnesota 55905, USA
Alcohol Clin Exp Res 26:1939-41. 2002
Iqmik--a form of smokeless tobacco used by pregnant Alaska natives: nicotine exposure in their neonatesRichard D Hurt
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
J Matern Fetal Neonatal Med 17:281-9. 2005..To determine the concentration of nicotine and cotinine in maternal blood and neonatal cord blood among pregnant Alaska Native women and to assess the neonates for neurobehavioral effects...
Bupropion for pharmacologic relapse prevention to smoking: predictors of outcomeRichard D Hurt
Nicotine Research Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Addict Behav 27:493-507. 2002..These data should encourage others to perform similar pharmacologic relapse prevention studies with this or other pharmacotherapies...
Treating nondepressed smokers with alcohol dependence in sustained full remission: nicotine patch therapy tailored to baseline serum cotinineRichard D Hurt
Nicotine Dependence Center, Mayo Clinic College of Medicine, 200 First Street South West, Rochester, Minnesota 55905, USA
J Stud Alcohol 66:506-16. 2005....
Preventing lung cancer by stopping smokingRichard D Hurt
Nicotine Dependence Center, Division of Community Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
Clin Chest Med 23:27-36, vii. 2002..The use of these medications can be tailored to meet the patients needs and combinations of these medications can be used when appropriate. More intensive treatment, such as residential treatment, may be needed for more addicted smokers...
New medications for nicotine dependence treatmentR D Hurt
Nicotine Dependence Center, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Nicotine Tob Res 1:S175-9; discussion S207-10. 1999..3) What are the best combination treatments and which smokers are best suited for combination treatment? (4) Will other similar pharmacological agents with dopaminergic/noradrenergic activity have efficacy similar to bupropion?..
Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levelsR D Hurt
Nicotine Dependence Center, Division of Community Internal Medicine, Mayo Clinic, Rochester, Minn, USA
Arch Pediatr Adolesc Med 154:31-7. 2000..To determine the efficacy of nicotine patch therapy in adolescents who want to stop smoking and to assess biochemical markers of smoking and nicotine intake...
Relation between smoking cessation and receiving results from three annual spiral chest computed tomography scans for lung carcinoma screeningCynthia O Townsend
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 103:2154-62. 2005..Further research is needed to continue to investigate how annual screening may enhance motivation for health behavior change...
Bupropion SR for the treatment of smokeless tobacco useLowell C Dale
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Drug Alcohol Depend 90:56-63. 2007..We conducted a multicenter, randomized, double-blind, placebo-controlled, clinical trial to assess the efficacy and safety of bupropion SR for tobacco abstinence among ST users...
Change in smoking status after spiral chest computed tomography scan screeningLisa Sanderson Cox
Nicotine Research Center, Mayo Clinic, Rochester, Minnesota 55905, USA
Cancer 98:2495-501. 2003..Further research is needed to evaluate the potential avenues through which lung carcinoma screening can be used as an opportunity for providing effective nicotine interventions...
Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depressionLisa Sanderson Cox
Nicotine Dependence Center Research Program, Mayo Clinic, Rochester, Minnesota 55905, USA
J Gen Intern Med 19:828-34. 2004..CONCLUSIONS: Extended use of bupropion for relapse prevention is effective for smokers with and without a history of major depression...
The effect of nicotine patch therapy on depression in nonsmokers: a preliminary studyLisa Sanderson Cox
Nicotine Research Center, Mayo Clinic, Rochester, MN 55905, USA
J Addict Dis 22:75-85. 2003..Among the placebo participants, the mean HRSD score decreased (p = 0.038) by Day 2. The study needs replication with a larger sample and utilizing novel recruitment strategies...
A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholicsJ Taylor Hays
Department of Internal Medicine, Mayo Clinic College of Medicine, Mayo Clinic Nicotine Dependence Center, 200 1st Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:859-67. 2009..We set out to investigate this issue further by conducting a randomized, double-blind, placebo-controlled trial of bupropion sustained-release (SR) for smoking relapse prevention among abstinent alcoholic smokers...
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot studyJ Taylor Hays
Mayo Clinic, Nicotine Dependence Center, Rochester, Minnesota 55905, USA
J Subst Abuse Treat 40:102-7. 2011..No serious adverse events were reported. Varenicline may be a useful aid for treating tobacco dependence among smokers who are in stable recovery from alcohol dependence. Further study of this treatment is warranted...
Treating tobacco dependence: review of the best and latest treatment optionsJon O Ebbert
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
J Thorac Oncol 2:249-56. 2007..We review the currently available pharmacologic approaches to the treatment of tobacco dependence...
Nicotine lozenges for the treatment of smokeless tobacco useJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 9:233-40. 2007..Future phase III clinical trials investigating the efficacy of nicotine lozenges are warranted...
Expressive writing as a smoking cessation treatment adjunct for young adult smokersSteven C Ames
Mayo Clinic Cancer Center, Jacksonville, FL 32224, USA
Nicotine Tob Res 9:185-94. 2007..Therefore, other modes of delivering expressive writing to young adult cigarette smokers should be explored...
Residential treatment compared with outpatient treatment for tobacco use and dependenceJ Taylor Hays
Nicotine Dependence Center, Mayo Clinic, Rochester, MN 55905, USA
Mayo Clin Proc 86:203-9. 2011..To compare the effectiveness of outpatient vs residential treatment for tobacco dependence in a large referral practice...
Development and feasibility of a parental support intervention for adolescent smokersSteven C Ames
Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida 32224, USA
Subst Use Misuse 43:497-511. 2008..This study expands on the knowledge of treating adolescent smokers and presents a new assessment measure. The study's limitations are noted. This investigation was funded by NICHHD...
Nicotine percentage replacement among smokeless tobacco users with nicotine patchJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Drug Alcohol Depend 89:223-6. 2007..We conclude that the use of 42 mg/day nicotine patch therapy is safe and should be considered as initial therapy in the clinical setting among ST users who use > or =3 cans/week...
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse preventionIvana T Croghan
Nicotine Research Center, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905, USA
Mayo Clin Proc 82:186-95. 2007..To compare the combination of a nicotine inhaler and bupropion to either treatment alone for initiating smoking abstinence and relapse prevention...
Validation of the revised Self-Administered Alcohol Screening Test (SAAST-R)Christi A Patten
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Addict 15:409-21. 2006..The SAAST-R was found to have good sensitivity and specificity among both males and females...
Second primary tumors following tobacco dependence treatments among head and neck cancer patientsYolanda I Garces
Division of Radiation Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Am J Clin Oncol 30:531-9. 2007....
Combination pharmacotherapy for stopping smoking: what advantages does it offer?Jon O Ebbert
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Drugs 70:643-50. 2010..Available data suggests that combination therapy may increase abstinence rates compared with monotherapy. However, the cost effectiveness of this approach has not been clearly demonstrated...
Cough following initiation of smoking abstinenceDavid O Warner
Mayo Clinic, Rochester, MN 55905, USA
Nicotine Tob Res 9:1207-12. 2007..We conclude that an initial increase in cough is unlikely to occur among relatively healthy smokers who stop smoking and that changes in cough do not represent a barrier to maintaining abstinence for most smokers...
Feasibility of an exercise counseling intervention for depressed women smokersKristin S Vickers
Department of Psychiatry and Psychology, Mayo Clinic Rochester, 200 First Street South West, Rochester, MN 55905, USA
Nicotine Tob Res 11:985-95. 2009..This pilot study investigated the feasibility of an exercise intervention for depressed female smokers (Center for Epidemiological Studies Depression Scale [CES-D] score > or =16)...
Combination treatment with varenicline and nicotine replacement therapyJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:572-6. 2009..A paucity of data exists regarding the safety and effectiveness of combination treatment with varenicline and nicotine replacement therapy (NRT)...
Varenicline and bupropion sustained-release combination therapy for smoking cessationJon O Ebbert
Mayo Clinic College of Medicine, 200 1st Street Southwest, Rochester, MN 55905, USA
Nicotine Tob Res 11:234-9. 2009..Combination pharmacotherapy with these agents may increase long-term smoking abstinence rates above what is observed with single-agent therapy...
The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohortIvana T Croghan
Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
Breast J 15:489-95. 2009..81, p < 0.001). In this referral practice having a personal history of smoking is predictive of breast cancer diagnosis. Further studies are needed to further explore this relationship...
Waking a sleeping giant: the tobacco industry's response to the polonium-210 issueMonique E Muggli
Nicotine Research Program, Mayo Clinic, Rochester, MN 55905, USA
Am J Public Health 98:1643-50. 2008..Tobacco companies continue to minimize their knowledge about polonium-210 in cigarettes in smoking and health litigation. Cigarette packs should carry a radiation-exposure warning label...
Changes in readiness to quit and self-efficacy among adolescents receiving a brief office intervention for smoking cessationChristi A Patten
Department of Psychiatry and Psychology and the Behavioral Health Research Program, Mayo Clinic College of Medicine, Rochester, MN, USA
Psychol Health Med 13:326-36. 2008..To examine changes in readiness to quit and self-efficacy among adolescents who received a clinic-based, brief office intervention (BOI) for smoking cessation...
Change in perceived stress, partner support, decisional balance, and self-efficacy following residential nicotine dependence treatmentSteven C Ames
Mayo Clinic, Division of Hematology and Oncology, 4500 San Pablo Road, Jacksonville, FL 32224, USA
J Addict Dis 27:73-82. 2008..This study provides new information about how residential treatment impacts psychosocial factors considered to be important predictors of tobacco abstinence in outpatient settings...
"Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in ChinaMonique E Muggli
Mayo Clinic, Rochester, Minnesota, USA
PLoS Med 5:1729-69. 2008..Internal tobacco industry documents show that transnational tobacco companies (TTCs) have pursued a multifaceted strategy for undermining the adoption of restrictions on smoking in many countries...
Tobacco use and cessation among pregnant Alaska Natives from Western Alaska enrolled in the WIC program, 2001-2002Christi A Patten
Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, Charlton 6 273, 200 First Street SW, Rochester, MN 55905, USA
Matern Child Health J 12:30-6. 2008....
Focus groups of Alaska Native adolescent tobacco users: preferences for tobacco cessation interventions and barriers to participationChristi A Patten
Mayo Clinic College of Medicine, Rochester, Minnesota 55901, USA
Health Educ Behav 36:711-23. 2009..Parents were perceived as potentially supportive to the adolescent in quitting tobacco. The findings will be used to develop tobacco cessation programs for Alaska Native youth...
Randomized clinical trial of an Internet-based versus brief office intervention for adolescent smoking cessationChristi A Patten
Mayo Clinic College of Medicine, Department of Psychiatry and Psychology, Rochester, MN 55905, USA
Patient Educ Couns 64:249-58. 2006..Evaluation of novel treatment delivery methods, such as the Internet are notably absent from the adolescent smoking treatment literature...
A prospective, case-control study of tobacco dependence in thromboangiitis obliterans (Buerger's Disease)Leslie T Cooper
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN 55905, USA
Angiology 57:73-8. 2006..03). In contrast to case reports of extreme tobacco dependence in the TAO population, the degree of tobacco dependence in subjects with TAO is similar to that in subjects with CAD...
A cigarette manufacturer and a managed care company collaborate to censor health information targeted at employeesMonique E Muggli
Nicotine Research Program, Mayo Clinic, St. Paul, MN 55905, USA
Am J Public Health 94:1307-11. 2004..We recommend that accrediting bodies mandate that health plans not censor employee-directed health information at the request of employers...
Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched-pair analysisYolanda I Garces
Department of Oncology, Division of Radiation Oncology, Mayo Clinic, Charlton Building, Desk R, 200 First Street SW, Rochester, MN 55905, USA
Cancer 101:116-24. 2004..The current study described tobacco use outcomes among patients with head and neck carcinoma who underwent treatment for nicotine dependence at the Mayo Clinic Nicotine Dependence Center (NDC; Rochester, MN)...
Residential treatment for smokeless tobacco use: a case seriesJon O Ebbert
Nicotine Dependence Center, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
J Subst Abuse Treat 26:261-7. 2004..More research is needed to replicate our findings and determine if comparable abstinence rates can be achieved with outpatient ST treatment programs using similar behavioral and pharmacotherapies...
Training support persons to help smokers quit: a pilot studyChristi A Patten
Nicotine Research Program, Departmetn of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota 55905, USA
Am J Prev Med 26:386-90. 2004..Evaluate the feasibility, acceptability, and potential efficacy of a skills-training intervention for adults interested in helping someone to stop smoking (i.e., support persons)...
Effectiveness of smoking cessation self-help materials in a lung cancer screening populationMatthew M Clark
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
Lung Cancer 44:13-21. 2004..Clearly, more investigation is warranted into how to tailor smoking interventions for cancer screening participants...
Cotinine as a biomarker of systemic nicotine exposure in spit tobacco usersJon O Ebbert
Department of Internal Medicine, Division of Community Medicine, Mayo Clinic, Rochester, MN 55905, USA
Addict Behav 29:349-55. 2004....
Depressed versus nondepressed young adult tobacco users: differences in coping style, weight concerns and exercise levelKristin S Vickers
Mayo Clinic, Nicotine Research Program, Section of Patient Education, Rochester, MN 55905, USA
Health Psychol 22:498-503. 2003..Multivariate logistic regression analysis indicated that higher maladaptive coping and lower level of exercise were significantly associated with depression among tobacco users...
Differences in adolescent smoker and nonsmoker perceptions of strategies that would help an adolescent quit smokingChristi A Patten
Mayo Clinic, Rochester, MN 55905, USA
Ann Behav Med 26:124-33. 2003..The results have implications for the design of peer-based and other interventions for adolescent smokers...
Predictors of 6-month tobacco abstinence among 1224 cigarette smokers treated for nicotine dependenceJennifer A Ferguson
Section of Biostatistics, Mayo Clinic and Mayo Foundation, 200 First Street SW, Colonial 3, Rochester, MN 55905, USA
Addict Behav 28:1203-18. 2003..Assessment of these variables may be useful clinically by assisting health care providers in tailoring nicotine dependence interventions to enhance outcomes...
Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized settingGary A Croghan
Mayo Clinic and Mayo Foundation Rochester MN 55905, USA
Nicotine Tob Res 5:181-7. 2003..Combination nicotine nasal spray and nicotine patches were delivered safely in a nonspecialized outpatient clinical setting and enhanced short-term smoking abstinence rates, but these rates were not sustained at 6 months...
Treatment of tobacco dependence in alcoholicsRichard D Hurt
Nicotine Dependence Center, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
Recent Dev Alcohol 16:335-59. 2003..However, the efficacy of several pharmacologic therapies for alcoholic smokers needs to be tested. In addition, further research is needed on effective treatments for recovering alcoholics of various racial/ethnic backgrounds...
Relationship of tobacco use to depressive disorders and suicidality among patients treated for alcohol dependenceChristi A Patten
Nicotine Research Center, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA
Am J Addict 12:71-83. 2003..Tobacco use status was unrelated to a DD diagnosis after discharge from the IAP and was not associated with SA...
Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot studyLowell C Dale
Division of Community Internal Medicine, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
Nicotine Tob Res 4:267-74. 2002..2 +/- 5.0 kg in the placebo group (p = 0.49). Bupropion may increase abstinence rates in ST users and appears to attenuate weight gain during ST abstinence. Larger randomized, controlled trials of bupropion for ST users are needed...
Simultaneous analysis of nicotine, nicotine metabolites, and tobacco alkaloids in serum or urine by tandem mass spectrometry, with clinically relevant metabolic profilesThomas P Moyer
Drug Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
Clin Chem 48:1460-71. 2002..Absence of nicotine metabolites and anabasine can be used to document abstinence from tobacco products, an indicator of treatment success...
Weight concerns among male smokersMatthew M Clark
Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Addict Behav 29:1637-41. 2004..Motivation to quit smoking was found to be significantly lower in those with weight concerns (P < .001). Further investigation is needed to enable the tailoring of interventions for weight-concerned male smokers...
Expressive writing intervention for young adult cigarette smokersSteven C Ames
Mayo Clinic, Division of Hematology and Oncology, Jacksonville, Florida 32224, USA
J Clin Psychol 61:1555-70. 2005..Participants stated they benefited most from the support and structure associated with the brief office intervention. Enthusiasm was lacking for the expressive writing treatment adjunct...
The prevalence of weight concerns in a smoking abstinence clinical trialMatthew M Clark
Mayo Clinic Mayo Building W11, 200 First Street, SW, Rochester, MN 55905, USA
Addict Behav 31:1144-52. 2006..Additionally, being weight concerned may impact the short-term success rates of stopping smoking using pharmacotherapy...
Personality correlates related to tobacco abstinence following treatmentW Michael Hooten
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Int J Psychiatry Med 35:59-74. 2005..The five-factor model of personality was used to describe the correlates of smoking abstinence...
Effect of high-dose nicotine patch therapy on tobacco withdrawal symptoms among smokeless tobacco usersJon O Ebbert
Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Nicotine Tob Res 9:43-52. 2007..High-dose nicotine patch therapy is safe and well tolerated in this population of tobacco users...
Revision of the Self-Administered Alcoholism Screening Test (SAAST-R): a pilot studyKristin S Vickers-Douglas
Nicotine Dependence Center, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
Subst Use Misuse 40:789-812. 2005..Areas for refinement in the format and items of the SAAST-R were identified and suggestions for further validation studies are presented...
Blowing smoke: British American Tobacco's air filtration schemeNadine Rae Leavell
Mayo Clinic Nicotine Research Program, Rochester, MN 55905, USA
BMJ 332:227-9. 2006
Body image treatment for weight concerned smokers: a pilot studyMatthew M Clark
Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905, USA
Addict Behav 30:1236-40. 2005..At week 12, 7(35%) of the body image participants had 7-day point prevalence smoking abstinence, compared to 5(24%) of the participants in the weight management group (p=0.505)...
Legislating tolerance: Spain's national public smoking lawMonique E Muggli
Mayo Clinic Nicotine Research Program, 127 Orlin Ave SE, Rochester, MN 55414, USA
Tob Control 19:24-30. 2010..In doing so, Spain's smoke-free public places law would be better aligned with the Framework Convention on Tobacco Control...
Is smoking related to body image satisfaction, stress, and self-esteem in young adults?Ivana T Croghan
Nicotine Dependence Program, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
Am J Health Behav 30:322-33. 2006..To examine the association of smoking and gender with body image satisfaction, perceived stress, and self-esteem in young adults...
Tobacco use during pregnancy among Alaska Natives in western AlaskaCaroline C Renner
Alaska Native Tribal Health Consortium, Office of Alaska Native Health Research, 4201 Tudor Centre Drive, Suite 105, Anchorage, AK 99508, USA
Alaska Med 47:12-6. 2005..To determine tobacco use rates during pregnancy among Alaska Natives residing on the Yukon-Kuskokwim (Y-K) Delta of western Alaska. Alaska Natives residing in this region use Iqmik, a unique form of smokeless tobacco (ST)...
Characteristics of six-month tobacco use outcomes of Black patients seeking smoking cessation interventionAnita F Fernander
Department of Behavioral Science, College of Medicine, University of Kentucky, USA
J Health Care Poor Underserved 17:413-24. 2006..I. 22% to 37%). An individualized nicotine dependence intervention conducted in an academic medical setting yielded encouraging abstinence rates for Black smokers...
Tobacco use outcomes among patients with lung cancer treated for nicotine dependenceLisa Sanderson Cox
Nicotine Research Center, Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
J Clin Oncol 20:3461-9. 2002..CONCLUSION: The results suggest that nicotine dependence treatment is effective for patients with a diagnosis of lung cancer. The majority of lung cancer patients were motivated to stop smoking...
Effects of gender on relapse prevention in smokers treated with bupropion SRDavid Gonzales
Department of Medicine, Oregon Health and Science University, Portland 97201, USA
Am J Prev Med 22:234-9. 2002..Lower abstinence and higher relapse rates are often reported for women treated with NRT. Gender effects for those treated with non-nicotinic, bupropion-hydrochloride sustained release for relapse prevention have not been studied...
Iqmik: a form of smokeless tobacco used among Alaska nativesCaroline C Renner
Office of Alaska Native Health Research, Alaska Native Tribal Health Consortium, Anchorage, AK 99508, USA
Am J Health Behav 29:588-94. 2005..To describe a homemade form of smokeless tobacco known as Iqmik used among Alaska Natives residing in western Alaska...
Tobacco and other substance use among Alaska Native youth in western AlaskaSarah Angstman
Department of Psychology, University of Montana, Missoula, MT, USA
Am J Health Behav 31:249-60. 2007..To examine tobacco, alcohol, and other drug use rates among Alaska Native youth from western Alaska...
Focus groups of Y-K Delta Alaska Natives: attitudes toward tobacco use and tobacco dependence interventionsCaroline C Renner
Yukon--Kuskokwim Health Corporation, Bethel, AK, USA
Prev Med 38:421-31. 2004..CONCLUSION: The attitudes toward tobacco and identified barriers to stopping will be useful in developing tobacco dependence interventions for Alaska Natives...
Urinary tobacco alkaloid measurement in patients having thromboangiitis obliteransRichard D Hurt
Mayo Clin Proc 83:1187-8; author reply 1188. 2008
Nicotine dependence treatment: perceived health status improvement with 1-year continuous smoking abstinenceIvana T Croghan
Nicotine Research Program, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
Eur J Public Health 15:251-5. 2005....
Exploring the association of John Henry active coping and education on smoking behavior and nicotine dependence among Blacks in the USAAnita F Fernander
Department of Behavioral Science, College of Medicine, 103 College of Medicine Office Building, University of Kentucky, Lexington, KY 40536, USA
Soc Sci Med 60:491-500. 2005....
Science for hire: a tobacco industry strategy to influence public opinion on secondhand smokeMonique E Muggli
Nicotine Tob Res 5:303-14. 2003..We suggest heightened monitoring of industry-created scientific organizations, further tobacco document research, and wide dissemination of such work...
Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smokeMonique E Muggli
Tobacco Document Consultancy, St. Paul, MN 55105, USA
Prev Med 39:568-80. 2004..Certainly, on the topic of the health effects of secondhand smoke, more scrutiny is warranted from these organizations for articles written by their members lest the public be misinformed and thus ill served...
A race to the death: British American Tobacco and the Chinese Grand PrixJeff Collin
Centre on Global Change and Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK
Lancet 364:1107-8. 2004
Research Grants
- Efficacy of Methylphenidate for treating tobacco dependenceRichard Hurt; Fiscal Year: 2007..If the results from this preliminary study support the performance of a larger clinical trial, then a future grant application will be submitted through the R01 research project grant mechanism. ..
- Tobacco Industry Documents on ETS-The Next FrontRichard Hurt; Fiscal Year: 2007....
- Tobacco Industry Documents on ETS-The Next FrontRichard Hurt; Fiscal Year: 2004..abstract_text> ..
- BUPROPION AND BEHAVIORAL TREATMENT FOR YOUNGER SMOKERSRichard Hurt; Fiscal Year: 2002..Primary assessments will be point prevalence smoking abstinence rates at end of treatment (week 12) and at 52 weeks. ..
